会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Implantable microstimulator system for prevention of disorders
    • 用于预防疾病的植入性微刺激系统
    • US06181965B2
    • 2001-01-30
    • US09490920
    • 2000-01-25
    • Gerald E. LoebFrances J. R. Richmond
    • Gerald E. LoebFrances J. R. Richmond
    • A61N100
    • A61N1/375A61N1/08A61N1/326A61N1/36003A61N1/3605A61N1/37205A61N1/37211A61N1/37235A61N1/3756
    • Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control includes memory for programming preferred stimulation patterns for later activation by the patient or caregiver.
    • 改进的可植入微刺激剂被生物相容的聚合物涂层覆盖,以便为胶囊提供增强的强度,并且如果它被机械地破坏,则捕获微刺激剂的碎片。 这种涂层还使微型刺激仪更安全,更易于处理。 涂层可以包括以受控方式释放到周围组织中的一种或多种可扩散化学试剂。 选择化学试剂,如营养因子,抗生素,激素,神经递质和其他药物,以产生所需的生理作用,以帮助,支持或补充电刺激的作用。 此外,根据本发明的微刺激剂提供了预防和/或治疗与延长的不活动,限制或固定一种或多种肌肉相关的各种障碍的系统。 这种疾病包括压力性溃疡,静脉栓塞,自主神经反射异常,感觉痉挛和肌肉萎缩。 微型激励器系统包括用于控制微型激励器的操作的外部控制。 控制器包括用于编程优选刺激模式的存储器,以供稍后由患者或看护者激活。
    • 4. 发明授权
    • Method of reducing the incidence of medical complications using implantable microstimulators
    • 使用可植入微刺激剂降低并发症发生率的方法
    • US06185455B2
    • 2001-02-06
    • US09490919
    • 2000-01-25
    • Gerald E. LoebFrances J. R. Richmond
    • Gerald E. LoebFrances J. R. Richmond
    • A61N100
    • A61N1/375A61N1/08A61N1/326A61N1/36003A61N1/3605A61N1/37205A61N1/37211A61N1/37235A61N1/3756
    • Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control include memory for programming preferred stimulation patterns for later activation by the patient or caregiver.
    • 改进的可植入微刺激剂被生物相容的聚合物涂层覆盖,以便为胶囊提供增强的强度,并且如果它被机械地破坏,则捕获微刺激剂的碎片。 这种涂层还使微型刺激仪更安全,更易于处理。 涂层可以包括以受控方式释放到周围组织中的一种或多种可扩散化学试剂。 选择化学试剂,如营养因子,抗生素,激素,神经递质和其他药物,以产生所需的生理作用,以帮助,支持或补充电刺激的作用。 此外,根据本发明的微刺激剂提供了预防和/或治疗与延长的不活动,限制或固定一种或多种肌肉相关的各种障碍的系统。 这种疾病包括压力性溃疡,静脉栓塞,自主神经反射异常,感觉痉挛和肌肉萎缩。 微型激励器系统包括用于控制微型激励器的操作的外部控制。 该控制器包括用于编程优选刺激模式的存储器,用于由患者或看护者稍后激活。
    • 5. 发明授权
    • Implantable stimulator methods for treatment of incontinence and pain
    • 用于治疗失禁和疼痛的植入式刺激器方法
    • US06941171B2
    • 2005-09-06
    • US09931804
    • 2001-08-16
    • Carla M. MannTodd K. WhitehurstJames P. McGivernGerald E. LoebFrances J. R. Richmond
    • Carla M. MannTodd K. WhitehurstJames P. McGivernGerald E. LoebFrances J. R. Richmond
    • A61N1/00A61N1/34A61N1/36A61N1/372
    • A61N1/36007A61N1/36017A61N1/36071A61N1/37205
    • A method and system for treatment of incontinence, urgency, frequency, and/or pelvic pain includes implantation of electrodes on a lead or the discharge portion of a catheter adjacent the perineal nerve(s) or tissue(s) to be stimulated. Stimulation pulses, either electrical or drug infusion pulses, are supplied by a stimulator implanted remotely, and through the lead or catheter, which is tunneled subcutaneously between the stimulator and stimulation site. For instance, the system and method reduce or eliminate the incidence of unintentional episodes of bladder emptying by stimulating nerve pathways that diminish involuntary bladder contractions, improve closure of the bladder outlet, and/or improve the long-term health of the urinary system by increasing bladder capacity and period between emptying. Moreover, the system and method allow a patient to be taught to receive one or more patterns of neural stimulation that can be prescribed by a physician and administered without continuous oversight by a clinical practitioner.
    • 用于治疗失禁,紧迫性,频率和/或骨盆疼痛的方法和系统包括将电极植入导联或导管的排出部分,邻近会阴神经或要刺激的组织。 刺激脉冲(电或药物输注脉冲)由远程植入的刺激器和通过刺激器和刺激部位之间皮下隧道穿过的导联或导管提供。 例如,该系统和方法通过刺激神经通路降低或消除膀胱排空的无意发作,从而减少无意识的膀胱收缩,改善膀胱出口的闭合,和/或通过增加泌尿系统的长期健康来改善 膀胱容量和排空期间。 此外,该系统和方法允许患者接受一种或多种神经刺激模式,其可由医师处方并由临床医师进行无持续监督。
    • 6. 发明授权
    • Implantable microstimulator system for producing repeatable patterns of electrical stimulation
    • 用于产生电刺激模式的可植入微刺激系统
    • US06175764B1
    • 2001-01-16
    • US09490921
    • 2000-01-25
    • Gerald E. LoebFrances J. R. Richmond
    • Gerald E. LoebFrances J. R. Richmond
    • A61N100
    • A61N1/375A61N1/08A61N1/326A61N1/36003A61N1/3605A61N1/37205A61N1/37211A61N1/37235A61N1/3756
    • Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control include memory for programming preferred stimulation patterns for later activation by the patient or caregiver.
    • 改进的可植入微刺激剂被生物相容的聚合物涂层覆盖,以便为胶囊提供增强的强度,并且如果它被机械地破坏,则捕获微刺激剂的碎片。 这种涂层还使微型刺激仪更安全,更易于处理。 涂层可以包括以受控方式释放到周围组织中的一种或多种可扩散化学试剂。 选择化学试剂,如营养因子,抗生素,激素,神经递质和其他药物,以产生所需的生理作用,以帮助,支持或补充电刺激的作用。 此外,根据本发明的微刺激剂提供了预防和/或治疗与延长的不活动,限制或固定一种或多种肌肉相关的各种障碍的系统。 这种疾病包括压力性溃疡,静脉栓塞,自主神经反射异常,感觉痉挛和肌肉萎缩。 微型激励器系统包括用于控制微型激励器的操作的外部控制。 该控制器包括用于编程优选刺激模式的存储器,用于由患者或看护者稍后激活。
    • 7. 发明授权
    • System and method for providing recovery from muscle denervation
    • 从肌肉去神经支配提供恢复的系统和方法
    • US06937904B2
    • 2005-08-30
    • US10022562
    • 2001-12-12
    • Frances J. R. RichmondGerald E. LoebTessa Gordon
    • Frances J. R. RichmondGerald E. LoebTessa Gordon
    • A61N1/36A61N1/10
    • A61N1/36103A61N1/36146A61N1/37205
    • Recovery from peripheral nerve and nerve plexus injuries is usually slow and incomplete because the regenerating motor axons often head erroneously toward sensory receptors rather than muscle fibers and because the target muscles atrophy while waiting for the slow process of reinnervation. Research has suggested that electrical stimulation with different waveforms and temporal patterns at different times during the regeneration process might improve the clinical outcome through various mechanisms, but a practical means to deliver such stimulation has been lacking. This invention teaches the use of miniature electrical stimulators that can be implanted alongside the injured nerve(s) at the time of surgical repair and that can be powered and controlled by transmission of radiofrequency energy from outside the body so as to provide a variety of electrical stimuli at different times during the recovery process.
    • 从周围神经和神经丛损伤的恢复通常是缓慢和不完整的,因为再生运动轴突通常头错误地朝向感觉受体而不是肌肉纤维,并且因为目标肌肉萎缩同时等待缓慢的再狭窄过程。 研究表明,再生过程中不同波形和不同时期的电刺激可能会通过各种机制改善临床结果,但是缺乏实现这种刺激的实用手段。 本发明教导了使用微型电刺激器,其可以在手术修复时被植入在受伤的神经旁边,并且可以通过从身体外部传输射频能量来供电和控制,以便提供各种电气 刺激在恢复过程中的不同时间。
    • 9. 发明授权
    • Implantable microstimulation system for treatment of sleep apnea
    • 用于治疗睡眠呼吸暂停的植入式微刺激系统
    • US06240316B1
    • 2001-05-29
    • US09370082
    • 1999-08-06
    • Frances J. R. RichmondGerald E. Loeb
    • Frances J. R. RichmondGerald E. Loeb
    • A61N136
    • A61N1/3601A61N1/37205A61N1/3727A61N1/37288
    • One or more implantable microminiature electronic devices, termed “microstimulators”, are used to treat sleep apnea. The microstimulators are implanted at strategic locations within the patient and are then controlled in a manner so as to stimulate muscle and nerve tissue in a constructive manner which helps open blocked airways. In one embodiment, the microstimulators sense blockage of a patient's airway and provide electrical stimuli in a closed loop fashion to open the airway. In another embodiment, at least one microstimulator treats sleep apnea in an open loop fashion by providing electrical stimulation pulses in a rhythm or cycle having a period corresponding approximately to the natural respiratory rhythm of the patient. Such open loop stimulation entrains the patient's respiratory rate to follow the pattern set by the microstimulator so that stimulation is applied to open the airway during a period of inspiration by the patient. The microstimulator devices receive power and programming (control) signals by inductive or RF coupling from an external transmitter, either during actual use by the sleeping patient or during recharging periods in the awake patient.
    • 一种或多种可植入式微型电子装置,称为“微型刺激器”,用于治疗睡眠呼吸暂停。 微型刺激器植入患者内的战略位置,然后以一种有助于打开阻塞气道的建设性方式刺激肌肉和神经组织的方式进行控制。 在一个实施例中,微刺激器感测到患者气道的阻塞并以闭环方式提供电刺激以打开气道。 在另一个实施例中,至少一个微刺激器通过以具有对应于患者的自然呼吸节律的周期的节律或循环中的电刺激脉冲来以开环方式治疗睡眠呼吸暂停。 这种开环刺激使得患者的呼吸频率遵循由微刺激器设定的模式,使得在患者的吸气期间施加刺激以打开呼吸道。 微型激励器装置通过来自外部发射器的感应或RF耦合来接收电力和编程(控制)信号,无论是在睡眠患者实际使用期间还是在唤醒患者中的充电期间。
    • 10. 发明授权
    • System for implanting a microstimulator
    • 用于植入微型激励器的系统
    • US06214032B1
    • 2001-04-10
    • US09490922
    • 2000-01-25
    • Gerald E. LoebFrances J. R. Richmond
    • Gerald E. LoebFrances J. R. Richmond
    • A61N100
    • A61N1/375A61N1/08A61N1/326A61N1/36003A61N1/3605A61N1/37205A61N1/37211A61N1/37235A61N1/3756
    • Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control includes memory for programming preferred stimulation patterns for later activation by the patient or caregiver.
    • 改进的可植入微刺激剂被生物相容的聚合物涂层覆盖,以便为胶囊提供增强的强度,并且如果它被机械地破坏,则捕获微刺激剂的碎片。 这种涂层还使微型刺激仪更安全,更易于处理。 涂层可以包括以受控方式释放到周围组织中的一种或多种可扩散化学试剂。 选择化学试剂,如营养因子,抗生素,激素,神经递质和其他药物,以产生所需的生理作用,以帮助,支持或补充电刺激的作用。 此外,根据本发明的微刺激剂提供了预防和/或治疗与延长的不活动,限制或固定一种或多种肌肉相关的各种障碍的系统。 这种疾病包括压力性溃疡,静脉栓塞,自主神经反射异常,感觉痉挛和肌肉萎缩。 微型激励器系统包括用于控制微型激励器的操作的外部控制。 控制器包括用于编程优选刺激模式的存储器,以供稍后由患者或看护者激活。